Susana Almeida, PhD
Clinical Development and Safety Director
Medicines for Europe
Dr. Susana Almeida is Clinical Development and Safety Director at Medicines for Europe (formerly EGA). Before joining Medicines for Europe, Susana was the Chair of the Association’s Bioequivalence Working Group for almost 15 years. She has worked in clinical trials and pharmacovigilance in Europe and in North America, and her experience includes the pharmaceutical industry and clinical research organizations.
She has overseen the conduction of dozens of clinical trials carried out in Europe, North and South America and Asia.
At Medicines for Europe, Susana is responsible for the coordination of multiple working groups, working on different aspects involving policy and regulatory science: Susana coordinates the activities related to clinical development, pharmacovigilance/drug safety, and medical devices (single integral products, Medical Device Regulation article 117).
She has represented the International Generic and Biosimilar Medicines Association (IGBA) in multiple Expert Working Groups at the International Council for Harmonisation (ICH): M13, Generic Discussion Group and M9. She is also involved in the Therapeutics Pillar of the Access to COVID-19 Tools (ACT) Accelerator partnership, launched by WHO and partners.
She holds a PhD in Clinical Pharmacology from the Faculty of Medicine, Universidad Autònoma de Barcelona (UAB), Spain and has authored several scientific papers.